Filters: author is Knibbe [Clear All Filters]
- 2009
Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling,
Drug Discov Today, vol. 14, no. 5-6, pp. 316-20.
- 2008
Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients,
Clin Pharmacol Ther, vol. 83, no. 3, pp. 443-51.
Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients,
Eur J Clin Pharmacol, vol. 64, no. 3, pp. 329-34.
- 2006
Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgery,
Anesthesiology, vol. 104, no. 3, pp. 466-74.
Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery,
Anesthesiology, vol. 105, no. 6, pp. 1135-46.
- 2005
Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery,
Br J Anaesth, vol. 94, no. 5, pp. 630-5.
Allometric relationships between the pharmacokinetics of propofol in rats, children and adults,
Br J Clin Pharmacol, vol. 59, no. 6, pp. 705-11.
- 2004
Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg(-1) ml in critically ill, mechanically ventilated patients,
Acta Anaesthesiol Scand, vol. 48, no. 3, pp. 302-7.
- 2002
Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery,
Br J Clin Pharmacol, vol. 54, no. 4, pp. 415-22.
Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%,
Clin Pharmacol Ther, vol. 72, no. 6, pp. 670-84.
- 2000
Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery,
Eur J Clin Pharmacol, vol. 56, no. 1, pp. 89-95.
- 1999
Pilot study in humans on the pharmacokinetics and safety of propofol 6% SAZN,
Pharm World Sci, vol. 21, no. 5, pp. 239-40.
Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection,
Br J Clin Pharmacol, vol. 47, no. 6, pp. 653-60.
- 1998
Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol,
Pharm Res, vol. 15, no. 3, pp. 442-8.



